SAN DIEGO, June 15 /PRNewswire-FirstCall/ -- Metabasis Therapeutics (Nasdaq: MBRX - News) will host a conference call and live webcast today, Thursday, June 15, 2006 at 1:30 p.m. Pacific Time to provide a summary of Metabasis’ presentations at the 2006 American Society of Clinical Oncology (ASCO) and American Diabetes Association (ADA) Scientific Sessions and provide an opportunity for questions on Metabasis’ current development programs. Dr. Mark Erion, executive vice president of research and development and CSO, Dr. Howard Foyt, vice president of clinical development, and Dr. Paul Laikind, chairman, president and CEO, will participate in the call.
